Further, ex vivo whole blood stimulation with IFN-β or polyinosinic:polycytidylic acid, a synthetic dsRNA analog and activator of Toll-like receptor 3 (TLR3), has revealed an IFN-1 hyper-responsiveness in T1D patients compared to healthy controls8. Here, TLR3 is linked to type 1 diabetes mellitus.